US 7,429,667 B2
Phenylamino isothiazole carboxamidines as MEK inhibitors
Hassan Abdellaoui, Aliso Viejo, Calif. (US); Robert Tam, Irvine, Calif. (US); Huanming Chen, Irvine, Calif. (US); Varaprasad Chamakura, Irvine, Calif. (US); Dinesh Barawkar, Foothill Ranch, Calif. (US); Andreas Maderna, Los Angeles, Calif. (US); Zhi Hong, Irvine, Calif. (US); and Stanley Lang, Laguna Niguel, Calif. (US)
Assigned to Ardea Biosciences, Inc., San Diego, Calif. (US)
Filed on Jan. 20, 2006, as Appl. No. 11/337,243.
Claims priority of provisional application 60/691698, filed on Jun. 16, 2005.
Claims priority of provisional application 60/688628, filed on Jun. 07, 2005.
Claims priority of provisional application 60/688006, filed on Jun. 06, 2005.
Claims priority of provisional application 60/688005, filed on Jun. 06, 2005.
Claims priority of provisional application 60/685194, filed on May 26, 2005.
Claims priority of provisional application 60/685131, filed on May 26, 2005.
Claims priority of provisional application 60/675397, filed on Apr. 27, 2005.
Claims priority of provisional application 60/653340, filed on Feb. 16, 2005.
Claims priority of provisional application 60/645425, filed on Jan. 20, 2005.
Prior Publication US 2006/0194802 A1, Aug. 31, 2006
Int. Cl. C07D 275/03 (2006.01); C07D 413/12 (2006.01); C07D 239/36 (2006.01); C07D 217/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 417/12 (2006.01)
U.S. Cl. 548—213  [544/145; 544/298; 544/367; 546/145; 546/171; 546/209; 546/256; 546/271.1] 13 Claims
 
1. A compound of formula I

OG Complex Work Unit Drawing
where Ar1 is phenyl, pyridyl, pyrimidyl, pyridazinyl, or triazinyl, in which all ring carbon atoms are optionally substituted with substituents R1, R2, and R3, which are selected independently from hydrogen; halogen; hydroxy; nitro; cyano; C1-C4 alkyl, optionally substituted with one to three fluorine atoms; CH3O; 2-methoxy ethenyl; (CH3)2N; CH3OC(O); CH3CH2OC(O); NR7R8, —C(O)NR7R8; or —S(O)2NR7R8, where R7 and R8 are, independently, H, CH3, or CH3CH2; and R1 may also be 2-C(O)K, where K is selected from:
—OJ, where J is isopropyl, cyclopropyl, cyclopentyl, dimethylamino, or methoxyethyl;
—NHJ′ where J′ is methyl, ethyl, isopropyl, cyclopropyl, dimethylaminomethyl, or 3-methyl-2-yl-butanoic acid methyl ester; and
—N(CH3)2; or 4-methylpiperzin-1-yl;
or R1 and R2 are attached to adjacent carbons and, together with the ring atoms to which they are attached, form an additional, fused, five- or six-membered ring, optionally containing one heteroatom, which ring may be aromatic or aliphatic;
A is O, S, CH2, N2, CO, NHCO, COCH2, or CH2CO;
or Ar1-A is

OG Complex Work Unit Drawing
where the five-membered ring is fused to Ar1 and Y is NH, S, or O;
or Ar1-A is

OG Complex Work Unit Drawing
where the dotted line represents an optional double bond, the five-membered ring is fused to Ar1, and Rx is selected from substituents listed above for R3;
or Ar1-A is

OG Complex Work Unit Drawing
where the five-membered ring is fused to Ar1, and Rx is selected from substituents listed above for R3;
Ar2 is phenyl, pyridyl, pyrimidyl, pyridazinyl, or triazinyl, where ring carbon atoms are optionally substituted with substituents R4-R6 which are selected independently from H, F, Cl, Br, CH3, or CF3;
or Ar2—NH— is

OG Complex Work Unit Drawing
where Ry is selected from substituents listed above for R3;
and R′ is OH; O—C1-C6 alkyl; C1-C6 alkyl, said C1-C6 alkyl groups optionally substituted with one to three groups selected independently from hydroxy, halogen, C1-C3 alkoxy, and phenyl; —CH2B or —CH2CH2B, where B is selected from C3-7 cycloalkyl, C7-C9 bicycloalkyl, pyridyl, piperazinyl, piperidinyl, N-morpholyl, tetrahydrofuryl, and naphthyl; C3-C7 cycloalkyl; C7-C9 bicycloalkyl, where all cycloalkyl, bicycloalkyl, pyridyl, piperazinyl, piperidinyl, N-morpholyl, tetrahydrofuryl, and naphthyl groups are optionally substituted with one to three groups selected independently from hydroxy, halogen, and methyl;
or R′ is (CH2)n-G, where n is 1 or 2 and G is a five- or six-membered ring or a 9-14-membered fused ring system, wherein each ring optionally contains 1-3 heteroatoms selected independently from O, N, and S; wherein each ring is optionally substituted with 1-3 groups selected independently from the following: halogen, hydroxy, cyano, oxo, and C1-C4 alkyl, wherein said C1-C4 alkyl group is optionally substituted with one to three halogen atoms; and wherein each ring optionally contains one or more double bonds;
or R′ is —CH(CH2OH)CH2D, where D is selected from imidazolyl, indolyl, carboxamido, phenyl, cyclohexyl, —CH2SCH3, and adamantin-1-yl.